Agfa formally introduced its medAr electronic patient record system at the European Congress of Radiology as part of the company’s strategy to move beyond the radiology industry and into the healthcare enterprise product market.Developed by
Agfa formally introduced its medAr electronic patient record system at the European Congress of Radiology as part of the company’s strategy to move beyond the radiology industry and into the healthcare enterprise product market.
Developed by Quadrat, an Agfa-owned company headquartered in Sint-Martens-Latem, Belgium, medAr encompasses six separate modules: Medfile, for enterprise-wide result distribution; QPlanner for electronic ordering of exams and appointment scheduling; QPoli for clinical examination management and coding; QdReport for report generation; Billing Link for billing; and DRG for disease-related group statistics.
medAr has been installed in five sites in Belgium and is slated for installation in the 3500-bed hospital at the University of Montpellier, France. By the end of 2001, Agfa hopes to have 24 medAr installations completed.
The system is integrated with the Agfa RIS and PACS systems, allowing the assessment of images and patient data, according to Tom De Caluwé, Quadrat business development manager.
“It’s one of the advantages of the system in that it doesn’t have the linking problems you can find with other systems,” he said.
medAr was shown as a work-in-progress at the 2001 Healthcare Information and Management Systems Society conference in New Orleans. Agfa does not expect the system to be launched in the U.S. during 2001 but showed it at HIMSS to gain feedback from possible future customers and also to give attendees a chance to compare it with competing products from companies like Cerner and GE Medical. Agfa believes medAr’s data security features will meet the standards of the Health Insurance Portability and Accountability Act (HIPAA), although those have yet to be finalized.
“We are in a good position competitively, as our system was designed from the beginning as an integrated, enterprise-wide product,” Caluwé said. “Most of our competitors come from the result or nursing side and do not have the same smooth integration.”
medAr represents Agfa’s first step into the potentially huge, $40 billion enterprise products market, according to Caluwé.
“At the moment we are staying in Belgium and France, but we will be expanding,” he said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.